Featured Research

from universities, journals, and other organizations

New combination therapy for hepatitis C

Date:
May 5, 2014
Source:
Medical University of Vienna
Summary:
A new combination therapy allows chronic hepatitis C to be treated in a manner that is less aggressive yet equally efficient, new research shows. “This is a revolutionary breakthrough in the treatment of this disease and represents a huge improvement in the quality of life of those affected,” says a hepatologist.Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus. The virus is transmitted mostly via direct contact with contaminated blood or blood products.

Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus. The virus is transmitted mostly via direct contact with contaminated blood or blood products. At-risk groups are primarily drug abusers who share needles with others. Transmission through everyday activities is virtually impossible.
Credit: Coloures-Pic / Fotolia

A new combination therapy allows chronic hepatitis C to be treated in a manner that is less aggressive yet equally efficient. This is the result of a current study, led by primary author Peter Ferenci from the University Department of Internal Medicine III at the MedUni Vienna, which has been published in the highly New England Journal of Medicine. "This is a revolutionary breakthrough in the treatment of this disease and represents a huge improvement in the quality of life of those affected," says the Vienna hepatologist.

Related Articles


Ferenci and a global group of scientists were able to demonstrate using 419 test subjects with chronic hepatitis C that the combined use of the protease inhibitor ABT-450r, the NS5A inhibitor Ombitasvir and the non-nucleoside polymerase inhibitor Dasubavir yields significantly higher cure outcomes than the previous therapy which involves Ribavarin and the hormone interferon (mostly in combination with a protease inhibitor). These therapies also had considerable side effects. The test subjects in these current "PEARL" studies were all in the early stages of the disease, i.e. before liver cirrhosis had developed.

Twelve weeks of treatment: almost a 100-percent cure rate

Says Ferenci: "After just twelve weeks, we had achieved an almost 100-percent cure rate with this new, side-effect-free therapy." The therapy involves three tablets -- two in the morning and one in the evening. Until now, patients with hepatitis C had to take Ribavirin and the hormone interferon for up to 18 months, and the side effects were considerable. "Often, additional treatment was and is necessary," explains Ferenci. With the new combination therapy, which is also free of interferon, this additional therapy is not required.

Around 170 million people worldwide suffer from chronic hepatitis C, and in Austria these numbers are between 40,000 and 80,000. In cases of new infection, prompt and targeted therapy is vital, as it can prevent the disease developing into a chronic condition that can lead to inoperable liver cancer. In the Clinical Gastroenterology and Hepatology Unit at the University Department of Internal Medicine III, several hundred patients with chronic hepatitis C are currently seen and treated each year.

Due to the low number of symptoms, infected individuals often mistake the disease for a 'flu-like infection. The condition is in many cases diagnosed by a chance finding.

Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus. The virus is transmitted mostly via direct contact with contaminated blood or blood products. At-risk groups are primarily drug abusers who share needles with others. Transmission through everyday activities is virtually impossible.


Story Source:

The above story is based on materials provided by Medical University of Vienna. Note: Materials may be edited for content and length.


Journal Reference:

  1. Peter Ferenci et al. ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV. New England Journal of Medicine, 2014; 140504060027001 DOI: 10.1056/NEJMoa1402338

Cite This Page:

Medical University of Vienna. "New combination therapy for hepatitis C." ScienceDaily. ScienceDaily, 5 May 2014. <www.sciencedaily.com/releases/2014/05/140505093800.htm>.
Medical University of Vienna. (2014, May 5). New combination therapy for hepatitis C. ScienceDaily. Retrieved January 29, 2015 from www.sciencedaily.com/releases/2014/05/140505093800.htm
Medical University of Vienna. "New combination therapy for hepatitis C." ScienceDaily. www.sciencedaily.com/releases/2014/05/140505093800.htm (accessed January 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, January 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Oxfam Calls for Massive Aid for Ebola-Hit West Africa

Oxfam Calls for Massive Aid for Ebola-Hit West Africa

AFP (Jan. 29, 2015) Oxfam International has called for a multi-million dollar post-Ebola "Marshall Plan", with financial support given by wealthy countries, to help Guinea, Sierra Leone and Liberia to recover. Duration: 01:10 Video provided by AFP
Powered by NewsLook.com
Are We Winning The Fight Against Ebola?

Are We Winning The Fight Against Ebola?

Newsy (Jan. 29, 2015) The World Health Organization announced the fight against Ebola has entered its second phase as the number of cases per week has steadily dropped. Video provided by Newsy
Powered by NewsLook.com
Calif. Health Officials Campaign Against E-Cigarettes

Calif. Health Officials Campaign Against E-Cigarettes

Newsy (Jan. 29, 2015) The California Health Department says e-cigarettes are a public health risk for both smokers and those who inhale e-cig smoke secondhand. Video provided by Newsy
Powered by NewsLook.com
Measles Scare Sends 66 Calif. Students Home

Measles Scare Sends 66 Calif. Students Home

AP (Jan. 29, 2015) Officials say 66 students at a Southern California high school have been told to stay home through the end of next week because they may have been exposed to measles and are not vaccinated. (Jan. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins